title: Progression of double-hit lymphoma in the midst of R-hyper CVAD.
authors.affiliation: Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan, USA. javier.munoz@me.com
authors.forename: Javier
authors.initials: J
authors.lastname: Munoz
authors.forename: Mona
authors.initials: M
authors.lastname: Vekaria
authors.forename: Amr
authors.initials: A
authors.lastname: Hanbali
authors.forename: Nalini
authors.initials: N
authors.lastname: Janakiraman
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001706:Biopsy; D003520:Cyclophosphamide / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008224:Lymphoma, Follicular / Q000188:drug therapy* / Q000473:pathology*; D008479:Mediastinal Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D008875:Middle Aged; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D003907:Dexamethasone; D004317:Doxorubicin; D003520:Cyclophosphamide